Logo image of DAP.DE

DANAHER CORP (DAP.DE) Stock Fundamental Analysis

FRA:DAP - Deutsche Boerse Ag - US2358511028 - Common Stock - Currency: EUR

168.4  -3.44 (-2%)

Fundamental Rating

6

Taking everything into account, DAP scores 6 out of 10 in our fundamental rating. DAP was compared to 16 industry peers in the Life Sciences Tools & Services industry. DAP scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, DAP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year DAP was profitable.
In the past year DAP had a positive cash flow from operations.
In the past 5 years DAP has always been profitable.
In the past 5 years DAP always reported a positive cash flow from operatings.
DAP.DE Yearly Net Income VS EBIT VS OCF VS FCFDAP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

With a decent Return On Assets value of 4.76%, DAP is doing good in the industry, outperforming 75.00% of the companies in the same industry.
With a decent Return On Equity value of 7.40%, DAP is doing good in the industry, outperforming 75.00% of the companies in the same industry.
DAP has a Return On Invested Capital (5.97%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DAP is in line with the industry average of 6.90%.
Industry RankSector Rank
ROA 4.76%
ROE 7.4%
ROIC 5.97%
ROA(3y)6.35%
ROA(5y)6.24%
ROE(3y)10.31%
ROE(5y)10.73%
ROIC(3y)6.76%
ROIC(5y)6.52%
DAP.DE Yearly ROA, ROE, ROICDAP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

The Profit Margin of DAP (15.81%) is better than 100.00% of its industry peers.
DAP's Profit Margin has been stable in the last couple of years.
The Operating Margin of DAP (21.67%) is better than 93.75% of its industry peers.
In the last couple of years the Operating Margin of DAP has grown nicely.
Looking at the Gross Margin, with a value of 59.80%, DAP belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Gross Margin of DAP has remained more or less at the same level.
Industry RankSector Rank
OM 21.67%
PM (TTM) 15.81%
GM 59.8%
OM growth 3Y-5.38%
OM growth 5Y3.63%
PM growth 3Y-13.55%
PM growth 5Y-0.1%
GM growth 3Y-1.01%
GM growth 5Y1.35%
DAP.DE Yearly Profit, Operating, Gross MarginsDAP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

DAP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DAP has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DAP has been increased compared to 5 years ago.
Compared to 1 year ago, DAP has an improved debt to assets ratio.
DAP.DE Yearly Shares OutstandingDAP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DAP.DE Yearly Total Debt VS Total AssetsDAP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 4.31 indicates that DAP is not in any danger for bankruptcy at the moment.
DAP has a better Altman-Z score (4.31) than 93.75% of its industry peers.
The Debt to FCF ratio of DAP is 3.36, which is a good value as it means it would take DAP, 3.36 years of fcf income to pay off all of its debts.
DAP's Debt to FCF ratio of 3.36 is amongst the best of the industry. DAP outperforms 81.25% of its industry peers.
DAP has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, DAP belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.36
Altman-Z 4.31
ROIC/WACC0.59
WACC10.04%
DAP.DE Yearly LT Debt VS Equity VS FCFDAP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

DAP has a Current Ratio of 1.43. This is a normal value and indicates that DAP is financially healthy and should not expect problems in meeting its short term obligations.
DAP has a Current ratio (1.43) which is in line with its industry peers.
DAP has a Quick Ratio of 1.05. This is a normal value and indicates that DAP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DAP (1.05) is worse than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.05
DAP.DE Yearly Current Assets VS Current LiabilitesDAP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The earnings per share for DAP have decreased by -7.80% in the last year.
Measured over the past years, DAP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.77% on average per year.
Looking at the last year, DAP shows a small growth in Revenue. The Revenue has grown by 0.35% in the last year.
DAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.92% yearly.
EPS 1Y (TTM)-7.8%
EPS 3Y-9.37%
EPS 5Y9.77%
EPS Q2Q%-2.08%
Revenue 1Y (TTM)0.35%
Revenue growth 3Y-1.26%
Revenue growth 5Y5.92%
Sales Q2Q%-0.95%

3.2 Future

Based on estimates for the next years, DAP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.29% on average per year.
Based on estimates for the next years, DAP will show a small growth in Revenue. The Revenue will grow by 5.59% on average per year.
EPS Next Y3.51%
EPS Next 2Y7.73%
EPS Next 3Y8.8%
EPS Next 5Y9.29%
Revenue Next Year2.91%
Revenue Next 2Y4.82%
Revenue Next 3Y5.52%
Revenue Next 5Y5.59%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DAP.DE Yearly Revenue VS EstimatesDAP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
DAP.DE Yearly EPS VS EstimatesDAP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.59, which means the current valuation is very expensive for DAP.
Compared to the rest of the industry, the Price/Earnings ratio of DAP indicates a somewhat cheap valuation: DAP is cheaper than 68.75% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DAP to the average of the S&P500 Index (23.99), we can say DAP is valued inline with the index average.
With a Price/Forward Earnings ratio of 21.94, DAP is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DAP is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 20.35. DAP is around the same levels.
Industry RankSector Rank
PE 25.59
Fwd PE 21.94
DAP.DE Price Earnings VS Forward Price EarningsDAP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DAP is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DAP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.84
EV/EBITDA 20.45
DAP.DE Per share dataDAP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DAP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)7.29
PEG (5Y)2.62
EPS Next 2Y7.73%
EPS Next 3Y8.8%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.65%, DAP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.82, DAP pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.65, DAP pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

On average, the dividend of DAP grows each year by 6.91%, which is quite nice.
Dividend Growth(5Y)6.91%
Div Incr Years4
Div Non Decr Years4
DAP.DE Yearly Dividends per shareDAP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

20.85% of the earnings are spent on dividend by DAP. This is a low number and sustainable payout ratio.
DAP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP20.85%
EPS Next 2Y7.73%
EPS Next 3Y8.8%
DAP.DE Yearly Income VS Free CF VS DividendDAP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
DAP.DE Dividend Payout.DAP.DE Dividend Payout, showing the Payout Ratio.DAP.DE Dividend Payout.PayoutRetained Earnings

DANAHER CORP

FRA:DAP (5/7/2025, 7:00:00 PM)

168.4

-3.44 (-2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-22 2025-04-22/bmo
Earnings (Next)07-21 2025-07-21/amc
Inst Owners81.31%
Inst Owner ChangeN/A
Ins Owners10.97%
Ins Owner ChangeN/A
Market Cap120.52B
Analysts85
Price Target222.45 (32.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly Dividend0.93
Dividend Growth(5Y)6.91%
DP20.85%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.69%
Min EPS beat(2)-1.93%
Max EPS beat(2)13.3%
EPS beat(4)3
Avg EPS beat(4)6.89%
Min EPS beat(4)-1.93%
Max EPS beat(4)13.3%
EPS beat(8)7
Avg EPS beat(8)6.95%
EPS beat(12)11
Avg EPS beat(12)8.3%
EPS beat(16)15
Avg EPS beat(16)8.48%
Revenue beat(2)2
Avg Revenue beat(2)1.18%
Min Revenue beat(2)0.66%
Max Revenue beat(2)1.7%
Revenue beat(4)4
Avg Revenue beat(4)1.72%
Min Revenue beat(4)0.66%
Max Revenue beat(4)2.75%
Revenue beat(8)7
Avg Revenue beat(8)1.86%
Revenue beat(12)9
Avg Revenue beat(12)-3.82%
Revenue beat(16)12
Avg Revenue beat(16)-5.8%
PT rev (1m)-9.65%
PT rev (3m)-17.73%
EPS NQ rev (1m)-6.14%
EPS NQ rev (3m)-11.9%
EPS NY rev (1m)0.2%
EPS NY rev (3m)-5.54%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)1.26%
Revenue NY rev (3m)-1.85%
Valuation
Industry RankSector Rank
PE 25.59
Fwd PE 21.94
P/S 5.73
P/FCF 27.84
P/OCF 21.84
P/B 2.68
P/tB N/A
EV/EBITDA 20.45
EPS(TTM)6.58
EY3.91%
EPS(NY)7.67
Fwd EY4.56%
FCF(TTM)6.05
FCFY3.59%
OCF(TTM)7.71
OCFY4.58%
SpS29.39
BVpS62.74
TBVpS-11.96
PEG (NY)7.29
PEG (5Y)2.62
Profitability
Industry RankSector Rank
ROA 4.76%
ROE 7.4%
ROCE 7.12%
ROIC 5.97%
ROICexc 6.14%
ROICexgc 43.53%
OM 21.67%
PM (TTM) 15.81%
GM 59.8%
FCFM 20.58%
ROA(3y)6.35%
ROA(5y)6.24%
ROE(3y)10.31%
ROE(5y)10.73%
ROIC(3y)6.76%
ROIC(5y)6.52%
ROICexc(3y)7.22%
ROICexc(5y)6.94%
ROICexgc(3y)54.83%
ROICexgc(5y)57.37%
ROCE(3y)8.07%
ROCE(5y)7.78%
ROICexcg growth 3Y-10.53%
ROICexcg growth 5Y-4.54%
ROICexc growth 3Y-4.88%
ROICexc growth 5Y-2.88%
OM growth 3Y-5.38%
OM growth 5Y3.63%
PM growth 3Y-13.55%
PM growth 5Y-0.1%
GM growth 3Y-1.01%
GM growth 5Y1.35%
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.36
Debt/EBITDA 2.13
Cap/Depr 57.11%
Cap/Sales 5.65%
Interest Coverage 13.2
Cash Conversion 83.11%
Profit Quality 130.2%
Current Ratio 1.43
Quick Ratio 1.05
Altman-Z 4.31
F-Score6
WACC10.04%
ROIC/WACC0.59
Cap/Depr(3y)58.29%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.31%
Cap/Sales(5y)4.94%
Profit Quality(3y)120.48%
Profit Quality(5y)125.69%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.8%
EPS 3Y-9.37%
EPS 5Y9.77%
EPS Q2Q%-2.08%
EPS Next Y3.51%
EPS Next 2Y7.73%
EPS Next 3Y8.8%
EPS Next 5Y9.29%
Revenue 1Y (TTM)0.35%
Revenue growth 3Y-1.26%
Revenue growth 5Y5.92%
Sales Q2Q%-0.95%
Revenue Next Year2.91%
Revenue Next 2Y4.82%
Revenue Next 3Y5.52%
Revenue Next 5Y5.59%
EBIT growth 1Y3.28%
EBIT growth 3Y-6.57%
EBIT growth 5Y9.77%
EBIT Next Year11.01%
EBIT Next 3Y10.58%
EBIT Next 5Y9.84%
FCF growth 1Y-33.04%
FCF growth 3Y-9.16%
FCF growth 5Y9.82%
OCF growth 1Y-26.48%
OCF growth 3Y-7.16%
OCF growth 5Y11.1%